A drug-coated balloon yielded superior patency to percutaneous transluminal angioplasty in patients with de novo or restenotic arteriovenous fistula lesions, according to findings presented at the Cardiovascular and Interventional Radiological Society of Europe Annual Meeting.
The researchers randomly assigned 330 patients with end-stage renal disease requiring hemodialysis who had new or non-stented restenotic arteriovenous fistula lesions at 29 sites in the United States, Japan and New Zealand to receive the DCB (IN.PACT AV, Medtronic) or PTA.
No commercial support for this activity.
This activity is supported by an educational grant from Ultragenyx.
Search Healio's robust listing of national and international medical meetings.
Tell us what you think about Healio.com »
Get the latest news and education delivered to your inbox
©2019 Healio All Rights Reserved.